Global Health (BOM:543654) Long-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543654 Global Health Ltd BOM:543654
95 GF Score
Price ₹1,427.35
GF Value ₹1,573.50
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Global Health Long-Term Debt?

Global Health BOM:543654 +0.38% 95 Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543654 with a GF Score™ of 95/100 and a GF Value™ of ₹1,573.50 (Fairly Valued). The stock has 5 warning signs investors should review.

Global Health's Long-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Global Health's quarterly Long-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹6,011 Mil) but then declined from Mar. 2026 (₹6,011 Mil) to Jun. 2026 (₹0 Mil).

Global Health's annual Long-Term Debt declined from Mar. 2024 (₹2,835 Mil) to Mar. 2025 (₹2,641 Mil) but then increased from Mar. 2025 (₹2,641 Mil) to Mar. 2026 (₹6,011 Mil).

Global Health  (BOM:543654) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Global Health Long-Term Debt Related Terms

Global Health Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Global Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Health Long-Term Debt Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial 7,676.33 7,371.18 2,834.66 2,641.00 6,011.16

Global Health Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4,546.92 0.00 6,011.16 0.00
BOM:543654
95GF Score
Global Health Ltd BOM:543654
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹0 Mil mean?
Global Health (BOM:543654) has a Long-Term Debt of ₹0 Mil as of Jun. 2026.
Is Global Health's Long-Term Debt too high?
Global Health's current Long-Term Debt is ₹0 Mil. Overall, Global Health has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Global Health's Long-Term Debt compare to HCA and THC?
Global Health's Long-Term Debt of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Global Health's current Long-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,573.50, compared to a current price of ₹1,427.35 — trading 9.3% below its estimated fair value. The current Long-Term Debt is ₹0 Mil. Global Health's overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Global Health (BOM:543654), the current Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Global Health (BOM:543654) Overvalued in 2026?

Based on GuruFocus' analysis, Global Health stock appears to be undervalued. The current stock price of ₹1,427.35 is trading 9.3% below its estimated GF Value™ of ₹1,573.50. GuruFocus considers Global Health to be Fairly Valued.

Key valuation signals for BOM:543654:

  • Long-Term Debt: ₹0 Mil
  • GF Value™: ₹1,573.50 vs. price of ₹1,427.35 (9.3% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Global Health Business Description

Other Exchanges MEDANTA:India
Address Medanta - The Medicity, Sector-38, Gurugram, HR, IND, 122001
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
95GF Score

Get the complete analysis for BOM:543654

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,427.35
Price
₹1,573.50
GF Value